Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 39 min ago
Peer-reviewedCC BY 4.0Frontiers in Immunology

Editorial: Beyond conventional biomarkers: unlocking immunotherapy response through novel biomarkers or combinatorial approaches

  • Ünal Metin Tokat1
  • Nalan Akgul Babacan1
  • Mutlu Demiray1
  1. 1Precision Oncology Center, Medicana Health Group
Open at sourcePDFDOICite

Related

  1. Editorial: Evolving non-invasive biomarkers: chemokines and multi-omic profiling in NSCLC immunotherapy response
    Jacobo Rogado, Elisabet González del Portillo, Diego Casado Elía +1
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossref
  2. Editorial: Chemoresistance and immunotherapy in solid tumors
    Junchao Xu
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textOncologyCrossref
  3. Personalized Boolean network dynamic profiling and machine learning approaches to identify combinatorial treatments for prostate cancer
    Se Jin Kim, Sandra Salib, Barbara A. Foster +2
    Frontiers in pharmacologyPeer-reviewedCC BYFull textPharmacology & toxicologyEurope PMC
  4. Editorial: Community series in unveiling the next generation of cancer immunity & immunotherapy in lung cancer, volume II
    Nethaji Muniraj, Mohanraj Sadasivam, Chellappagounder Thangavel
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textOncologyCrossref
  5. Editorial: Novel approaches to overcome drug resistance in breast cancer
    Arunima Biswas, Somsubhra Nath
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossref

Cite

BibTeXRIS
BibTeX
@article{tokat2026editorial,
  title = {{Editorial: Beyond conventional biomarkers: unlocking immunotherapy response through novel biomarkers or combinatorial approaches}},
  author = {Ünal Metin Tokat and Nalan Akgul Babacan and Mutlu Demiray},
  journal = {Frontiers in Immunology},
  year = {2026},
  month = oct,
  doi = {10.3389/fimmu.2026.2013615},
  url = {https://www.frontiersin.org/articles/10.3389/fimmu.2026.2013615/full},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Editorial: Beyond conventional biomarkers: unlocking immunotherapy response through novel biomarkers or combinatorial approaches
AU  - Ünal Metin Tokat
AU  - Nalan Akgul Babacan
AU  - Mutlu Demiray
PY  - 2026
DA  - 2026/10/13
JO  - Frontiers in Immunology
DO  - 10.3389/fimmu.2026.2013615
UR  - https://www.frontiersin.org/articles/10.3389/fimmu.2026.2013615/full
SN  - 1664-3224
ER  -